CLINICAL TRIALS PROFILE FOR VASOTEC
✉ Email this page to a colleague
All Clinical Trials for Vasotec
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00248807 ↗ | A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury. | Completed | US Department of Veterans Affairs | N/A | 2005-10-01 | The purpose of this study is to determine how blood pressure and blood flow are controlled during head-up tilt in a semi-upright position. In this investigation we are studying blood pressure and blood flow to the brain, with and without a medication which lowers blood pressure (Vasotec). We will determine how persons with a spinal cord injury are able to maintain blood flow to the brain (not get dizzy) as they assume a more upright position and their blood pressure decreases. |
| NCT00248807 ↗ | A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury. | Completed | VA Office of Research and Development | N/A | 2005-10-01 | The purpose of this study is to determine how blood pressure and blood flow are controlled during head-up tilt in a semi-upright position. In this investigation we are studying blood pressure and blood flow to the brain, with and without a medication which lowers blood pressure (Vasotec). We will determine how persons with a spinal cord injury are able to maintain blood flow to the brain (not get dizzy) as they assume a more upright position and their blood pressure decreases. |
| NCT00741156 ↗ | The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution | Completed | The Hospital for Sick Children | Phase 3 | 2008-07-01 | The primary objective of this study is to study the acute effects of angiotensin-converting enzyme inhibitor (ACEI) on systemic, pulmonary and cerebral blood flow in post bidirectional cavopulmonary connection (BCPC) patients. |
| NCT00895414 ↗ | Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer | Completed | Masonic Cancer Center, University of Minnesota | N/A | 2009-04-01 | RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Enalapril maleate may help protect heart cells from the side effects of chemotherapy. It is not yet known whether giving enalapril maleate before or after doxorubicin hydrochloride is more effective in treating women with breast cancer. PURPOSE: This randomized clinical trial is studying giving enalapril maleate together with doxorubicin hydrochloride to see how well it works in treating women with breast cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Vasotec
Condition Name
Clinical Trial Locations for Vasotec
Trials by Country
Clinical Trial Progress for Vasotec
Clinical Trial Phase
Clinical Trial Sponsors for Vasotec
Sponsor Name
